Bernacki, S.
, Beck, J.
, Ackerstaff, K.
, Laurina, L.
, Amos, J.
, Snow-Bailey, K.
, Farkas, D.
, Friez, M.
, Hantash, F.
, Matteson, K.
, Monaghan, M.
, Muralidharan, K.
, Pratt, V.
, Prior, T.
, Richie, K.
, Levin, B.
, Rohlfs, E.
, Schaefer, F.
, Shrimpton, A.
, Spector, E.
, Stolle, C.
, Strom, C.
, Thibodeau, S.
, Cole, E.
, Goodman, B.
and Stenzel, T.
(2005),
Genetically characterized positive control cell lines derived from residual clinical blood samples, Clinical Chemistry
(Accessed December 12, 2024)
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Genetically characterized positive control cell lines derived from residual clinical blood samples
Published
Author(s)
S H. Bernacki, J C. Beck, K Ackerstaff, L O. Laurina, J Amos, K Snow-Bailey, D H. Farkas, M J. Friez, F M. Hantash, Karla J. Matteson, M G. Monaghan, Kasinathan Muralidharan, Victoria M. Pratt, Thomas W. Prior, , , Elizabeth M. Rohlfs, Fredrick V. Schaefer, A E. Shrimpton, Elaine B. Spector, C A. Stolle, C M. Strom, S N. Thibodeau, E C. Cole, B K. Goodman, T T. Stenzel
Citation
Clinical Chemistry
Volume
51
Issue
11
Pub Type
Journals
Citation
Issues
If you have any questions about this publication or are having problems accessing it, please contact reflib@nist.gov.
Created November 1, 2005, Updated February 17, 2017